Originally developed for managing Type 2 diabetes, drugs like semaglutide and tirzepatide have exploded in popularity as weight-loss treatments, fueling a market that analysts project will reach tens of billions of dollars in the coming years
The most common are gastrointestinal symptoms like nausea, vomiting, diarrhea, constipation, and cramps [13]
We do, because patients deserve to know what theyre walking into before they sit down
Supplementary Data 2 (download XLSX Statistical supporting data for Supplementary Fig
Ennis MA, Elango R
Alongside oestrogen imbalance linked to methylation challenges, we often see low glutathione, increased oxidative stress, and inflammation driving pigmentation